A study by Oxford University found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer PFE, -1.96% and Moderna MRNA, -4.34% vaccines as they are for the AstraZeneca AZN, -0.91% vaccine that was produced with the university’s help. According to the study, 4 in 1 million people experience cerebral venous thrombosis…
Tag: Moderna
Market Watch reports “Blood clots as prevalent with Pfizer and Moderna vaccine as with AstraZeneca’s: study”
A study by Oxford University found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer PFE, +0.05% and Moderna MRNA, +3.29% vaccines as they are for the AstraZeneca AZN, -0.85% vaccine that was produced with the university’s help. According to the study, 4 in 1 million people experience cerebral venous thrombosis…
NBC reports “Covid-19 booster shot likely needed within 12 months, Pfizer’s CEO says”
People will likely need a third dose of a Covid-19 vaccine within a year of getting fully vaccinated and may subsequently need annual shots to protect against the coronavirus, Pfizer’s CEO Albert Bourla said Thursday. Moderna is similarly studying an upgraded version of its Covid-19 vaccine that is specifically designed to target the South African variant, which…
Wall Street Journal reports “WHO Recommends Against Moderna, Pfizer Vaccines for Most Pregnant Women”
Neither Moderna nor Pfizer enrolled pregnant women in their Covid-19 vaccine trials, and both say they plan future study The World Health Organization released new guidance about Moderna Inc.’s Covid-19 vaccine this week, recommending generally against the use of the vaccine during pregnancy except in those at high risk of exposure or having a severe case. “In…
Children’s Health Defense reports “RFK, Jr. and CHD Take Action on Safety Concerns over Moderna’s COVID Vaccine”
On August 26, Children’s Health Defense (CHD) wrote a letter to Dr. Jerry Menikoff, Director of the Department of Health and Human Services’ Office of Human Research Protection (OHRP), asking for an investigation into serious safety concerns with the COVID-19 vaccine being developed by Moderna. Moderna’s version of the vaccine, championed by Dr. Anthony Fauci and…
London Real reports “Dr. David E. Martin – EXPOSING MODERNA; THE STAR OF PLANDEMIC: REVEALS THE TRUTH”
Until recently best known as the founder of M·CAM®, the international leader in innovation finance, trade, and intangible asset finance, David E. Martin is a modern day renaissance man, whose roles have included Professor, Lecturer, Chairman and CEO. From the halls of parliament to HBO comedy and documentary films such as the internationally acclaimed and multi-awarded Patent…
Children’s Health Defense reports “New Docs: NIH Owns Half of Moderna Vaccine”
New documents obtained by Axios and Public Citizen suggest that the National Institute of Health (NIH) owns half the key patent for Moderna’s controversial COVID vaccine and could collect half the royalties. In addition, four NIH scientists have filed their own provisional patent application as co-inventors. Little known NIH regulations let agency scientists collect up to $150,000.00 annually in royalties from vaccines upon…
Business Insider report “The ex-pharma exec leading Trump’s COVID-19 vaccine program has $10 million in stock options for a company getting federal funding”
Dr Moncef Slaoui, former pharma exec and chief Scientist for Trump’s “Operation Warp Speed,” which aims to develop a working Covid-19 vaccine as fast as possible, has more than $10 million in stock options in one of the companies receiving federal funding. Described across four separate filings, Slaoui has 155,438 options in Moderna. The stake…
Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Moderna, Inc. announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Regarding adverse effects: “To date, the most notable adverse events were seen at the 250 µg dose level, comprising…